XML 49 R32.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Share-Based Compensation (Tables)
 9 Months Ended
Nov. 02, 2019
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
The following table details share-based compensation expense and the related income tax benefit for the thirteen and thirty-nine weeks ended November 2, 2019 and November 3, 2018:
 
Thirteen Weeks Ended
 
Thirty-nine Weeks Ended
(in thousands)
November 2, 2019
 
November 3, 2018
 
November 2, 2019
 
November 3, 2018
Share-based compensation expense
$
5,796

 
$
5,957

 
$
8,464

 
$
16,896

Income tax benefit associated with share-based compensation expense recognized during the period
$
1,211

 
$
1,252

 
$
1,566

 
$
3,426
Share-based Payment Arrangement, Discrete Tax Benefit (Charge) [Table Text Block]
The following table details discrete income tax benefits and charges related to share-based compensation awards during the thirteen and thirty-nine weeks ended November 2, 2019 and November 3, 2018:
 
Thirteen Weeks Ended
 
Thirty-nine Weeks Ended
(in thousands)
November 2, 2019
 
November 3, 2018
 
November 2, 2019
 
November 3, 2018
Income tax discrete benefits realized for tax deductions related to the issuance of shares during the period
$
6

 
$
106

 
$
1,175

 
$
1,131

Income tax discrete charges realized upon cancellation of stock appreciation rights during the period
(447
)
 
(1,942
)
 
(611
)
 
(10,883
)
Total income tax discrete benefits (charges) related to share-based compensation awards
$
(441
)
 
$
(1,836
)
 
$
564

 
$
(9,752
)
Schedule of Restricted Stock Unit Activity
The following table summarizes activity for restricted stock units for the thirty-nine weeks ended November 2, 2019:
 
Service-based Restricted
Stock Units
 
Performance-based Restricted
Stock Units
 
Market-based Restricted
Stock Units
 
Number of 
Underlying
Shares (1)
 
Weighted-
Average Grant
Date Fair Value
 
Number of 
Underlying
Shares
 
Weighted-
Average Grant
Date Fair Value
 
Number of 
Underlying
Shares
 
Weighted-
Average Grant
Date Fair Value
Unvested at February 2, 2019
2,020,030

 
$
16.76

 
801,527

 
$
13.65

 
435,970

 
$
21.24

Granted
731,886

 
22.10

 
234,984

 
22.89

 
115,238

 
36.24

Adjustments for performance achievement
—

 
—

 
(90,616
)
 
24.06

 
(72,497
)
 
28.20

Vested
(736,858
)
 
17.76

 
—

 
—

 
(18,125
)
 
28.20

Forfeited
(288,194
)
 
16.62

 
(198,022
)
 
13.08

 
(38,802
)
 
29.90

Unvested at November 2, 2019
1,726,864

 
$
18.62

 
747,873

 
$
15.41

 
421,784

 
$
23.05



(1) 
Includes 259,016 unvested restricted stock units as of November 2, 2019, subject to vesting requirements related to the achievement of certain performance metrics, such as operating income and net income, for the fiscal year immediately preceding the vesting date. Holders of these restricted stock units have the opportunity to earn back one or more installments of the award if the cumulative performance requirements are met in a subsequent year.

Fa
Schedule of Stock Appreciation Rights Activity llows:
 
November 2, 2019
 
November 3, 2018
Grant date market price
$
25.34

 
$
23.59

Fair value
$
36.24

 
$
33.69

Assumptions:
 
 
 
Price volatility
57
%
 
54
%
Expected term (years)
2.9

 
2.9

Risk-free interest rate
2.2
%
 
2.4
%
Dividend yield
3.2
%
 
3.4
%
Average volatility of peer companies
40.0
%
 
37.4
%
Average correlation coefficient of peer companies
0.2407

 
0.2709

Stock appreciation rights

The following table summarizes stock appreciation rights activity for the thirty-nine weeks ended November 2, 2019:
 
Number of
Underlying
Shares
 
Weighted-Average
Exercise Price
 
Aggregate
Intrinsic Value
 
Weighted-Average
Remaining
Contractual Life (years)
Outstanding at February 2, 2019
1,041,867

 
$
37.81

 
 
 
 
Granted
—

 
—

 
 
 
 
Exercised
(43,463
)
 
22.41

 
 
 
 
Forfeited or expired
(201,679
)
 
32.27

 
 
 
 
Outstanding at November 2, 2019
796,725

 
$
40.06

 
$
—

 
2.6
Stock appreciation rights exercisable at November 2, 2019
796,100

 
$
40.08

 
$
—

 
2.6
Stock appreciation rights expected to become exercisable in the future as of November 2, 2019
607

 
$
22.55

 
$
—

 
6.2

Additional information pertaining to stock appreciation rights for the thirty-nine weeks ended November 2, 2019 and November 3, 2018 follows:
(in thousands)
November 2, 2019
 
November 3, 2018
Total grant date fair value of awards exercised
$
620

 
$
1,279
Market-based restricted stock units [Member]  
Schedule of Weighted-Average Estimated Fair Value and Assumptions of Restricted Stock Units with Market Vesting Conditions ditional information pertaining to restricted stock units for the thirty-nine weeks ended November 2, 2019 and November 3, 2018 follows:
(in thousands)
November 2, 2019
 
November 3, 2018
Service-based restricted stock units:
 
 
 
Total grant date fair value of awards granted
$
16,175

 
$
16,652

Total grant date fair value of awards vested
$
13,087

 
$
15,873

 
 
 
 
Performance-based restricted stock units:
 
 
 
Total grant date fair value of awards granted
$
5,379

 
$
4,310

Total grant date fair value of awards vested
$
—

 
$
—

 
 
 
 
Market-based restricted stock units:
 
 
 
Total grant date fair value of awards granted
$
4,176

 
$
4,784

Total grant date fair value of awards vested
$
511

 
$
137


The weighted-average assumptions used for market-based restricted stock units in the Monte Carlo simulation during the thirty-nine weeks ended November 2, 2019 and November 3, 2018 were as follows:
 
November 2, 2019
 
November 3, 2018
Grant date market price
$
25.34

 
$
23.59

Fair value
$
36.24

 
$
33.69

Assumptions:
 
 
 
Price volatility
57
%
 
54
%
Expected term (years)
2.9

 
2.9

Risk-free interest rate
2.2
%
 
2.4
%
Dividend yield
3.2
%
 
3.4
%
Average volatility of peer companies
40.0
%
 
37.4
%
Average correlation coefficient of peer companies
0.2407

 
0.2709